Efficacy and Safety of YD0743 Treatment for Sepsis-Associated ARDS
Clinical trial NCT07413094 · RECRUITING
Trial details
- NCT number
- NCT07413094
- Sponsor
- Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-02
- Primary completion
- 2026-12-01
- Enrollment
- 309
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.